Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With Sotatercept
ABSTRACT Sotatercept has recently expanded treatment options for pulmonary arterial hypertension (PAH), but its mental health and quality‐of‐life impact is not well characterized. We assessed psychiatric diagnoses and patient‐reported outcomes in PAH patients treated with sotatercept within the clin...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wiley
2026-04-01
|
| Серии: | Pulmonary Circulation |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1002/pul2.70324 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
